Epidermal growth factor receptor in breast cancer: storage conditions affecting measurement, and relationship to steroid receptors.
Author(s): McLeay WR, Horsfall DJ, Seshadri R, Morrison DA, Saccone GT
Publication: Breast Cancer Res Treat, 1992, Vol. 22, Page 141-51
PubMed ID: 1391979 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
This study determined whether the duration and temperature of frozen storage alters quantifiable epidermal growth factor receptor (EGF-R) activity in breast cancer tissue specimens.
Summary of Findings:
Quantifiable EGF-R activity in breast cancer specimens was reduced by approximately 75% after freezing irrespective of temperature or duration. Subsequent freezing of broken cell pellets prepared from frozen tissue specimens resulted in a total loss of EGF-R activity in the majority of specimens.
Biospecimens
Preservative Types
- Frozen
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform Protein Receptor binding Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Storage Storage temperature Liquid nitrogen
-20 degrees C
-70 degrees C
Storage Storage duration 2 d
5 d
7 d
14 d
21 d